Betamethasone Valerate + Gentamicin Sulfate

Verify with FDA CVM →

72 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
72
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Betamethasone ValerateGentamicin Sulfate

Administration Routes

UnknownTopical

Species Affected

Unknown 64
Dog 4
Cat 3
Horse 1

Most Affected Breeds

Unknown 66
Russian 2
Pit Bull 1
Boxer (German Boxer) 1
Whippet 1
Quarter Horse 1

Most Reported Reactions

Dispenser, Abnormal 17
Applicator, Abnormal 13
Product Defect, General 11
Underfilling, Container 8
Bottles, Damaged 8
Defect Unknown/Not Specified 5
Containers, Damaged 3
Hives (see also 'Skin') 2
Containers, Leaking 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Drooling 2
Swollen mouth 2

Outcome Breakdown

Recovered/Normal
6 (75.0%)
Ongoing
1 (12.5%)
Outcome Unknown
1 (12.5%)

Data Summary

Metric Value
Total adverse event reports 72
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 4
Distinct breeds in reports 6
Distinct reactions reported 20
Active ingredients on file 2

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Betamethasone Valerate + Gentamicin Sulfate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 72 adverse event reports referencing Betamethasone Valerate + Gentamicin Sulfate, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Betamethasone Valerate, Gentamicin Sulfate. Reported administration routes include Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Betamethasone Valerate + Gentamicin Sulfate reports are Unknown (64 reports), Dog (4 reports), Cat (3 reports), with Unknown accounting for the largest share. Within those species, Unknown (66), Russian (2), Pit Bull (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Betamethasone Valerate + Gentamicin Sulfate are Dispenser, Abnormal (17), Applicator, Abnormal (13), Product Defect, General (11), Underfilling, Container (8). Of the 8 reports with a coded outcome, Recovered/Normal is the leading category at 75.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Betamethasone Valerate + Gentamicin Sulfate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial